Cover Image
市場調查報告書

全球無菌注射劑市場

Global Market Study on Sterile Injectable Drugs: Cancer Application Segment to Significantly Contribute to the Growth of the Global Market During 2017 - 2025

出版商 Persistence Market Research 商品編碼 602294
出版日期 內容資訊 英文 218 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球無菌注射劑市場 Global Market Study on Sterile Injectable Drugs: Cancer Application Segment to Significantly Contribute to the Growth of the Global Market During 2017 - 2025
出版日期: 2017年12月18日 內容資訊: 英文 218 Pages
簡介

本報告提供全球無菌注射劑市場相關調查,彙整市場概要和各市場區隔,各地區趨勢,及加入此市場的主要企業的簡介等資料。

第1章 摘要整理

第2章 市場簡介

  • 市場定義
  • 市場分類
  • 市場預測比較

第3章 市場觀點

  • 宏觀經濟因素
  • 需求面促進要素
  • 隨從供應方面的促進因素
  • 阻礙要素
  • 趨勢
  • 機會分析
  • 專利失效方案

第4章 北美市場

  • 簡介
  • 各國分析
  • 各國預測
  • 各分子類型
  • 各藥物
  • 各用途
  • 各給藥途徑
  • 各流通管道
  • 促進因素與阻礙因素:影響分析
  • 市場魅力度分析
  • 市場參與企業
  • 市場參與企業的市場地位

第5章 南美市場

第6章 歐洲市場

第7章 亞太地區市場

第8章 中東·非洲市場

第9章 預測因素

第10章 預測的假設

第11章 競爭環境

  • 競爭儀表板
  • 企業簡介
    • Baxter International Inc.
    • Sanofi
    • GlaxoSmithKline plc.
    • AstraZeneca Plc.
    • Merck & Co., Inc.
    • Novartis AG
    • Pfizer Inc.
    • GILEAD SCIENCES, INC.
    • Johnson & Johnson Services, Inc.
    • hameln group gmbh

第12章 各地區市場分析與預測

  • 簡介
  • 各地區市場規模分析
    • 北美
    • 南美
    • 歐洲
    • 亞太地區
    • 中東·非洲
  • 市場魅力度分析

第13章 各分子類型市場分析與預測

  • 小分子
  • 大分子
  • 市場魅力度分析

第14章 藥物類別市場分析與預測

第15章 各用途市場分析與預測

第16章 各給藥途徑市場分析與預測

第17章 各流通管道市場分析與預測

第18章 市場分析與預測(2017∼2025年)

第19章 調查方法

圖表

目錄

This Persistence Market Research (PMR) report features the 'Sterile Injectable Drugs Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025)'. The report objective is to offer updates on the ongoing market trends and information regarding market opportunities in the global sterile injectable drugs market. This report by Persistence Market Research (PMR) examines sterile injectable drugs market for the period 2012-2025. The primary objective of the report is to offer insights into developments in the sterile injectable drugs market that are significantly transforming global businesses and enterprises.

The Sterile Injectable Drugs market segmented as follows:

  • Sterile Injectable Drugs Market, by molecule type
  • Sterile Injectable Drugs Market, by drug type
  • Sterile Injectable Drugs Market, by application
  • Sterile Injectable Drugs Market, by route of administration
  • Sterile Injectable Drugs Market, by distribution channel
  • Sterile Injectable Drugs Market, by region

The report uncovers the global sterile injectable drugs market performance concerning revenue contribution from various segments and their scenario across regions in the globe. This section also comprises of PMR analysis of key trends, drivers, challenges, and opportunities, which are influencing the growth of the global sterile injectable drugs market. Impact analysis of the key growth drivers and restraints are included in this report to provide clients with decision-making insights.

The sterile injectable drugs market report provides an overview of the market. This section also underlines factors influencing the growth of sterile injectable drugs market along with detailing of the key trends, drivers, challenges, and opportunities. Distinguishing features of the report includes a list of major vendors manufacturing workstations, drivers, and restraints regional impact analysis, and competitive dashboard. Furthermore, PMR provides a competitive landscape to the companies and their strategic developments.

The next section of the research report analyzes the market based on molecule type and presents the forecast in terms of value for the next eight years. Molecule type covered in the report include::

  • Small Molecules
  • Large Molecules

The subsequent section of the research report analyzes the market based on drug type and presents the forecast in terms of value for the next eight years. Drug type covered in the report include::

  • Monoclonal Antibodies (mAbs)
  • Cytokines
  • Insulin
  • Peptide hormones
  • Vaccines
  • Immunoglobulins
  • Blood Factors
  • Peptide antibiotics
  • Others

The following section of the research report analyzes the market based on application and presents the forecast in terms of value for the next eight years. Application covered in the report include::

  • Cancer
  • Diabetes
  • Cardiovascular Diseases
  • Musculoskeletal
  • CNS
  • Infections
  • Others

The next section of the research report analyzes the market based on route of administration and presents the forecast in terms of value for the next eight years. Route of administration covered in the report include::

  • Intravenous
  • Intramuscular (IM)
  • Subcutaneous (SC)
  • Others

The subsequent section of the research report analyzes the market based on distribution channel and presents the forecast in terms of value for the next eight years. Distribution channel covered in the report include::

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

The report focuses on the growth trends of the sterile injectable drugs market by regions namely, North America, Latin America, Europe, Asia-Pacific, Middle East & Africa. It provides an outlook for 2017-2025 & sets the forecast for sterile injectable drugs market. The market research report discusses regional trends contributing to the growth of the Sterile Injectable Drugs market worldwide, as well as analyses the extent to which drivers are influencing this market in each region. Regions covered in the report include::

  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia-Pacific (APAC)
    • Japan
    • China
    • Australia and New Zealand
    • India
    • ASEAN
    • Rest of APAC
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • North Africa
    • Rest of the Middle East and Africa

Also, we have considered the year-on-year growth to understand the predictability of the market and to identify the right growth opportunities in the global sterile injectable drugs market. An analysis of absolute dollar opportunity and incremental opportunity is conducted for primary segments of this report. Absolute dollar opportunity is usually overlooked while forecasting the market. However, it is the most critical factor for analysing the level of opportunities that a manufacturer can look to achieve, as well as to identify potential resources from a sales and delivery perspective.

In the final section of the sterile injectable drugs market report, 'Competitive Landscape' section is included to provide a detailed analysis with a dashboard view, to access the key differentiators among the competitor firms. Detailed profiles of major manufacturing companies is included with company-specific long-term and short-term strategies, company profiles are equipped with their product offerings and recent developments in the sterile injectable drugs market. This section can give the reader an idea of the new strategies that he/she can devise and implement with a view to gain competitive advantage.

Table of Contents

1. Executive Summary

  • 1.1. Market Overview
  • 1.2. Market Analysis
  • 1.3. PMR Analysis and Recommendations
  • 1.4. Wheel of Fortune

2. Market Introduction

  • 2.1. Market Definition
  • 2.2. Market Taxonomy
  • 2.3. Sterile Injectable Drugs Market Forecast Comparison

3. Market View Point

  • 3.1. Macro-Economic Factors
  • 3.2. Demand-Side Drivers
  • 3.3. Supply-Side Drivers
  • 3.4. Restraints
  • 3.5. Trends
  • 3.6. Opportunity Analysis
  • 3.7. Patent Expiration Scenario

4. North America Sterile Injectable Drugs Market Analysis 2012-2016 and Forecast 2017-2025

  • 4.1. Introduction
  • 4.2. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016
    • 4.2.1. U.S.
    • 4.2.2. Canada
  • 4.3. Market Size (US$ Mn) Forecast By Country, 2017-2025
    • 4.3.1. U.S.
    • 4.3.2. Canada
  • 4.4. Historical Market Size (US$ Mn) Analysis By Molecule Type, 2012-2016
    • 4.4.1. Small Molecules
    • 4.4.2. Large Molecules
  • 4.5. Market Size (US$ Mn) Forecast By Molecule Type, 2017-2025
    • 4.5.1. Small Molecules
    • 4.5.2. Large Molecules
  • 4.6. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012-2016
    • 4.6.1. Monoclonal Antibodies (mAbs)
    • 4.6.2. Cytokines
    • 4.6.3. Insulin
    • 4.6.4. Peptide hormones
    • 4.6.5. Vaccines
    • 4.6.6. Immunoglobulins
    • 4.6.7. Blood Factors
    • 4.6.8. Peptide antibiotics
    • 4.6.9. Others
  • 4.7. Market Size (US$ Mn) Forecast By Drug Type, 2017-2025
    • 4.7.1. Monoclonal Antibodies (mAbs)
    • 4.7.2. Cytokines
    • 4.7.3. Insulin
    • 4.7.4. Peptide hormones
    • 4.7.5. Vaccines
    • 4.7.6. Immunoglobulins
    • 4.7.7. Blood Factors
    • 4.7.8. Peptide antibiotics
    • 4.7.9. Others
  • 4.8. Historical Market Size (US$ Mn) Analysis By Application, 2012-2016
    • 4.8.1. Cancer
    • 4.8.2. Diabetes
    • 4.8.3. Cardiovascular Diseases
    • 4.8.4. Musculoskeletal
    • 4.8.5. CNS
    • 4.8.6. Infections
    • 4.8.7. Others
  • 4.9. Market Size (US$ Mn) Forecast By Application, 2017-2025
    • 4.9.1. Cancer
    • 4.9.2. Diabetes
    • 4.9.3. Cardiovascular Diseases
    • 4.9.4. Musculoskeletal
    • 4.9.5. CNS
    • 4.9.6. Infections
    • 4.9.7. Others
  • 4.10. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2016
    • 4.10.1. Intravenous
    • 4.10.2. Intramuscular (IM)
    • 4.10.3. Subcutaneous (SC)
    • 4.10.4. Others
  • 4.11. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2025
    • 4.11.1. Intravenous
    • 4.11.2. Intramuscular (IM)
    • 4.11.3. Subcutaneous (SC)
    • 4.11.4. Others
  • 4.12. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016
    • 4.12.1. Hospital Pharmacies
    • 4.12.2. Retail Pharmacies
    • 4.12.3. Online Pharmacies
  • 4.13. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2025
    • 4.13.1. Hospital Pharmacies
    • 4.13.2. Retail Pharmacies
    • 4.13.3. Online Pharmacies
  • 4.14. Drivers and Restraints: Impact Analysis
  • 4.15. Market Attractiveness Analysis
    • 4.15.1. By Country
    • 4.15.2. By Molecule Type
    • 4.15.3. By Drug Type
    • 4.15.4. By Application
    • 4.15.5. By Route of Administration
    • 4.15.6. By Distribution Channel
  • 4.16. Key Representative Market Participants
  • 4.17. Key Participants Market Presence (Intensity Map)

5. Latin America Sterile Injectable Drugs Market Analysis 2012-2016 and Forecast 2017-2025

  • 5.1. Introduction
  • 5.2. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016
    • 5.2.1. Brazil
    • 5.2.2. Mexico
    • 5.2.3. Rest of Latin America
  • 5.3. Market Size (US$ Mn) Forecast By Country, 2017-2025
    • 5.3.1. Brazil
    • 5.3.2. Mexico
    • 5.3.3. Rest of Latin America
  • 5.4. Historical Market Size (US$ Mn) Analysis By Molecule Type, 2012-2016
    • 5.4.1. Small Molecules
    • 5.4.2. Large Molecules
  • 5.5. Market Size (US$ Mn) Forecast By Molecule Type, 2017-2025
    • 5.5.1. Small Molecules
    • 5.5.2. Large Molecules
  • 5.6. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012-2016
    • 5.6.1. Monoclonal Antibodies (mAbs)
    • 5.6.2. Cytokines
    • 5.6.3. Insulin
    • 5.6.4. Peptide hormones
    • 5.6.5. Vaccines
    • 5.6.6. Immunoglobulins
    • 5.6.7. Blood Factors
    • 5.6.8. Peptide antibiotics
    • 5.6.9. Others
  • 5.7. Market Size (US$ Mn) Forecast By Drug Type, 2017-2025
    • 5.7.1. Monoclonal Antibodies (mAbs)
    • 5.7.2. Cytokines
    • 5.7.3. Insulin
    • 5.7.4. Peptide hormones
    • 5.7.5. Vaccines
    • 5.7.6. Immunoglobulins
    • 5.7.7. Blood Factors
    • 5.7.8. Peptide antibiotics
    • 5.7.9. Others
  • 5.8. Historical Market Size (US$ Mn) Analysis By Application, 2012-2016
    • 5.8.1. Cancer
    • 5.8.2. Diabetes
    • 5.8.3. Cardiovascular Diseases
    • 5.8.4. Musculoskeletal
    • 5.8.5. CNS
    • 5.8.6. Infections
    • 5.8.7. Others
  • 5.9. Market Size (US$ Mn) Forecast By Application, 2017-2025
    • 5.9.1. Cancer
    • 5.9.2. Diabetes
    • 5.9.3. Cardiovascular Diseases
    • 5.9.4. Musculoskeletal
    • 5.9.5. CNS
    • 5.9.6. Infections
    • 5.9.7. Others
  • 5.10. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2016
    • 5.10.1. Intravenous
    • 5.10.2. Intramuscular (IM)
    • 5.10.3. Subcutaneous (SC)
    • 5.10.4. Others
  • 5.11. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2025
    • 5.11.1. Intravenous
    • 5.11.2. Intramuscular (IM)
    • 5.11.3. Subcutaneous (SC)
    • 5.11.4. Others
  • 5.12. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016
    • 5.12.1. Hospital Pharmacies
    • 5.12.2. Retail Pharmacies
    • 5.12.3. Online Pharmacies
  • 5.13. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2025
    • 5.13.1. Hospital Pharmacies
    • 5.13.2. Retail Pharmacies
    • 5.13.3. Online Pharmacies
  • 5.14.Drivers and Restraints: Impact Analysis
  • 5.15. Market Attractiveness Analysis
    • 5.15.1. By Country
    • 5.15.2. By Molecule Type
    • 5.15.3. By Drug Type
    • 5.15.4. By Application
    • 5.15.5. By Route of Administration
    • 5.15.6. By Distribution Channel
  • 5.16. Key Representative Market Participants
  • 5.17. Key Participants Market Presence (Intensity Map)

6. Europe Sterile Injectable Drugs Market Analysis 2012-2016 and Forecast 2017-2025

  • 6.1. Introduction
  • 6.2. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016
    • 6.2.1. Germany
    • 6.2.2. France
    • 6.2.3. UK
    • 6.2.4. Italy
    • 6.2.5. Spain
    • 6.2.6. Russia
    • 6.2.7. Rest of Europe
  • 6.3. Market Size (US$ Mn) Forecast By Country, 2017-2025
    • 6.3.1. Germany
    • 6.3.2. France
    • 6.3.3. UK
    • 6.3.4. Italy
    • 6.3.5. Spain
    • 6.3.6. Russia
    • 6.3.7. Rest of Europe
  • 6.4. Historical Market Size (US$ Mn) Analysis By Molecule Type, 2012-2016
    • 6.4.1. Small Molecules
    • 6.4.2. Large Molecules
  • 6.5. Market Size (US$ Mn) Forecast By Molecule Type, 2017-2025
    • 6.5.1. Small Molecules
    • 6.5.2. Large Molecules
  • 6.6. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012-2016
    • 6.6.1. Monoclonal Antibodies (mAbs)
    • 6.6.2. Cytokines
    • 6.6.3. Insulin
    • 6.6.4. Peptide hormones
    • 6.6.5. Vaccines
    • 6.6.6. Immunoglobulins
    • 6.6.7. Blood Factors
    • 6.6.8. Peptide antibiotics
    • 6.6.9. Others
  • 6.7. Market Size (US$ Mn) Forecast By Drug Type, 2017-2025
    • 6.7.1. Monoclonal Antibodies (mAbs)
    • 6.7.2. Cytokines
    • 6.7.3. Insulin
    • 6.7.4. Peptide hormones
    • 6.7.5. Vaccines
    • 6.7.6. Immunoglobulins
    • 6.7.7. Blood Factors
    • 6.7.8. Peptide antibiotics
    • 6.7.9. Others
  • 6.8. Historical Market Size (US$ Mn) Analysis By Application, 2012-2016
    • 6.8.1. Cancer
    • 6.8.2. Diabetes
    • 6.8.3. Cardiovascular Diseases
    • 6.8.4. Musculoskeletal
    • 6.8.5. CNS
    • 6.8.6. Infections
    • 6.8.7. Others
  • 6.9. Market Size (US$ Mn) Forecast By Application, 2017-2025
    • 6.9.1. Cancer
    • 6.9.2. Diabetes
    • 6.9.3. Cardiovascular Diseases
    • 6.9.4. Musculoskeletal
    • 6.9.5. CNS
    • 6.9.6. Infections
    • 6.9.7. Others
  • 6.10. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2016
    • 6.10.1. Intravenous
    • 6.10.2. Intramuscular (IM)
    • 6.10.3. Subcutaneous (SC)
    • 6.10.4. Others
  • 6.11. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2025
    • 6.11.1. Intravenous
    • 6.11.2. Intramuscular (IM)
    • 6.11.3. Subcutaneous (SC)
    • 6.11.4. Others
  • 6.12. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016
    • 6.12.1. Hospital Pharmacies
    • 6.12.2. Retail Pharmacies
    • 6.12.3. Online Pharmacies
  • 6.13. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2025
    • 6.13.1. Hospital Pharmacies
    • 6.13.2. Retail Pharmacies
    • 6.13.3. Online Pharmacies
  • 6.14. Drivers and Restraints: Impact Analysis
  • 6.15. Market Attractiveness Analysis
    • 6.15.1. By Country
    • 6.15.2. By Molecule Type
    • 6.15.3. By Drug Type
    • 6.15.4. By Application
    • 6.15.5. By Route of Administration
    • 6.15.6. By Distribution Channel
  • 6.16. Key Representative Market Participants
  • 6.17. Key Participants Market Presence (Intensity Map)

7. Asia Pacific Sterile Injectable Drugs Market Analysis 2012-2016 and Forecast 2017-2025

  • 7.1. Introduction
  • 7.2. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016
    • 7.2.1. Japan
    • 7.2.2. China
    • 7.2.3. India
    • 7.2.4. A&NZ
    • 7.2.5. ASEAN
    • 7.2.6. Rest of APAC
  • 7.3. Market Size (US$ Mn) Forecast By Country, 2017-2025
    • 7.3.1. Japan
    • 7.3.2. China
    • 7.3.3. India
    • 7.3.4. A&NZ
    • 7.3.5. ASEAN
    • 7.3.6. Rest of APAC
  • 7.4. Historical Market Size (US$ Mn) Analysis By Molecule Type, 2012-2016
    • 7.4.1. Small Molecules
    • 7.4.2. Large Molecules
  • 7.5. Market Size (US$ Mn) Forecast By Molecule Type, 2017-2025
    • 7.5.1. Small Molecules
    • 7.5.2. Large Molecules
  • 7.6. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012-2016
    • 7.6.1. Monoclonal Antibodies (mAbs)
    • 7.6.2. Cytokines
    • 7.6.3. Insulin
    • 7.6.4. Peptide hormones
    • 7.6.5. Vaccines
    • 7.6.6. Immunoglobulins
    • 7.6.7. Blood Factors
    • 7.6.8. Peptide antibiotics
    • 7.6.9. Others
  • 7.7. Market Size (US$ Mn) Forecast By Drug Type, 2017-2025
    • 7.7.1. Monoclonal Antibodies (mAbs)
    • 7.7.2. Cytokines
    • 7.7.3. Insulin
    • 7.7.4. Peptide hormones
    • 7.7.5. Vaccines
    • 7.7.6. Immunoglobulins
    • 7.7.7. Blood Factors
    • 7.7.8. Peptide antibiotics
    • 7.7.9. Others
  • 7.8. Historical Market Size (US$ Mn) Analysis By Application, 2012-2016
    • 7.8.1. Cancer
    • 7.8.2. Diabetes
    • 7.8.3. Cardiovascular Diseases
    • 7.8.4. Musculoskeletal
    • 7.8.5. CNS
    • 7.8.6. Infections
    • 7.8.7. Others
  • 7.9. Market Size (US$ Mn) Forecast By Application, 2017-2025
    • 7.9.1. Cancer
    • 7.9.2. Diabetes
    • 7.9.3. Cardiovascular Diseases
    • 7.9.4. Musculoskeletal
    • 7.9.5. CNS
    • 7.9.6. Infections
    • 7.9.7. Others
  • 7.10. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2016
    • 7.10.1. Intravenous
    • 7.10.2. Intramuscular (IM)
    • 7.10.3. Subcutaneous (SC)
    • 7.10.4. Others
  • 7.11. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2025
    • 7.11.1. Intravenous
    • 7.11.2. Intramuscular (IM)
    • 7.11.3. Subcutaneous (SC)
    • 7.11.4. Others
  • 7.12. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016
    • 7.12.1. Hospital Pharmacies
    • 7.12.2. Retail Pharmacies
    • 7.12.3. Online Pharmacies
  • 7.13. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2025
    • 7.13.1. Hospital Pharmacies
    • 7.13.2. Retail Pharmacies
    • 7.13.3. Online Pharmacies
  • 7.14. Drivers and Restraints: Impact Analysis
  • 7.15. Market Attractiveness Analysis
    • 7.15.1. By Country
    • 7.15.2. By Molecule Type
    • 7.15.3. By Drug Type
    • 7.15.4. By Application
    • 7.15.5. By Route of Administration
    • 7.15.6. By Distribution Channel
  • 7.16. Key Representative Market Participants
  • 7.17. Key Participants Market Presence (Intensity Map)

8. MEA Sterile Injectable Drugs Market Analysis 2012-2016 and Forecast 2017-2025

  • 8.1. Introduction
  • 8.2. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016
    • 8.2.1. GCC Countries
    • 8.2.2. South Africa
    • 8.2.3. North Africa
    • 8.2.4. Rest of MEA
  • 8.3. Market Size (US$ Mn) Forecast By Country, , 2017-2025
    • 8.3.1. GCC Countries
    • 8.3.2. South Africa
    • 8.3.3. North Africa
    • 8.3.4. Rest of MEA
  • 8.4. Historical Market Size (US$ Mn) Analysis By Molecule Type, 2012-2016
    • 8.4.1. Small Molecules
    • 8.4.2. Large Molecules
  • 8.5. Market Size (US$ Mn) Forecast By Molecule Type, 2017-2025
    • 8.5.1. Small Molecules
    • 8.5.2. Large Molecules
  • 8.6. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012-2016
    • 8.6.1. Monoclonal Antibodies (mAbs)
    • 8.6.2. Cytokines
    • 8.6.3. Insulin
    • 8.6.4. Peptide hormones
    • 8.6.5. Vaccines
    • 8.6.6. Immunoglobulins
    • 8.6.7. Blood Factors
    • 8.6.8. Peptide antibiotics
    • 8.6.9. Others
  • 8.7. Market Size (US$ Mn) Forecast By Drug Type, 2017-2025
    • 8.7.1. Monoclonal Antibodies (mAbs)
    • 8.7.2. Cytokines
    • 8.7.3. Insulin
    • 8.7.4. Peptide hormones
    • 8.7.5. Vaccines
    • 8.7.6. Immunoglobulins
    • 8.7.7. Blood Factors
    • 8.7.8. Peptide antibiotics
    • 8.7.9. Others
  • 8.8. Historical Market Size (US$ Mn) Analysis By Application, 2012-2016
    • 8.8.1. Cancer
    • 8.8.2. Diabetes
    • 8.8.3. Cardiovascular Diseases
    • 8.8.4. Musculoskeletal
    • 8.8.5. CNS
    • 8.8.6. Infections
    • 8.8.7. Others
  • 8.9. Market Size (US$ Mn) Forecast By Application, 2017-2025
    • 8.9.1. Cancer
    • 8.9.2. Diabetes
    • 8.9.3. Cardiovascular Diseases
    • 8.9.4. Musculoskeletal
    • 8.9.5. CNS
    • 8.9.6. Infections
    • 8.9.7. Others
  • 8.10. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2016
    • 8.10.1. Intravenous
    • 8.10.2. Intramuscular (IM)
    • 8.10.3. Subcutaneous (SC)
    • 8.10.4. Others
  • 8.11. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2025
    • 8.11.1. Intravenous
    • 8.11.2. Intramuscular (IM)
    • 8.11.3. Subcutaneous (SC)
    • 8.11.4. Others
  • 8.12. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016
    • 8.12.1. Hospital Pharmacies
    • 8.12.2. Retail Pharmacies
    • 8.12.3. Online Pharmacies
  • 8.13. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2025
    • 8.13.1. Hospital Pharmacies
    • 8.13.2. Retail Pharmacies
    • 8.13.3. Online Pharmacies
  • 8.14. Drivers and Restraints: Impact Analysis
  • 8.15. Market Attractiveness Analysis
    • 8.15.1. By Country
    • 8.15.2. By Molecule Type
    • 8.15.3. By Drug Type
    • 8.15.4. By Application
    • 8.15.5. By Route of Administration
    • 8.15.6. By Distribution Channel
  • 8.16. Key Representative Market Participants
  • 8.17. Key Participants Market Presence (Intensity Map)

9. Forecast Factors: Relevance and Impact

10. Forecast Assumptions

11. Competition Landscape

  • 11.1. Competition Dashboard
  • 11.2. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 11.2.1. Baxter International Inc.
    • 11.2.2. Sanofi
    • 11.2.3. GlaxoSmithKline plc.
    • 11.2.4. AstraZeneca Plc.
    • 11.2.5. Merck & Co., Inc.
    • 11.2.6. Novartis AG
    • 11.2.7. Pfizer Inc.
    • 11.2.8. GILEAD SCIENCES, INC.
    • 11.2.9. Johnson & Johnson Services, Inc.
    • 11.2.10. hameln group gmbh

12. Global Sterile Injectable Drugs Market Analysis 2012-2016 and Forecast 2017-2025, By Region

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Analysis By Region, 2012-2016
    • 12.2.1. North America
    • 12.2.2. Latin America
    • 12.2.3. Europe
    • 12.2.4. Asia Pacific
    • 12.2.5. MEA
  • 12.3. Market Size (US$ Mn) Forecast By Region, 2017-2025
    • 12.3.1. North America
    • 12.3.2. Latin America
    • 12.3.3. Europe
    • 12.3.4. Asia Pacific
    • 12.3.5. MEA
  • 12.4. Market Attractiveness Analysis By Region

13. Global Sterile Injectable Drugs Market Analysis 2012-2016 and Forecast 2017-2025, By Molecule Type

  • 13.1. Historical Market Size (US$ Mn) Analysis By Molecule Type, 2012-2016
    • 13.1.1. Small Molecules
    • 13.1.2. Large Molecules
  • 13.2. Market Size (US$ Mn) Forecast By Molecule Type, 2017-2025
    • 13.2.1. Small Molecules
    • 13.2.2. Large Molecules
  • 13.3. Market Attractiveness Analysis By Molecule Type

14. Global Sterile Injectable Drugs Market Analysis 2012-2016 and Forecast 2017-2025, By Drug Type

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012-2016
    • 14.2.1. Monoclonal Antibodies (mAbs)
    • 14.2.2. Cytokines
    • 14.2.3. Insulin
    • 14.2.4. Peptide hormones
    • 14.2.5. Vaccines
    • 14.2.6. Immunoglobulins
    • 14.2.7. Blood Factors
    • 14.2.8. Peptide antibiotics
    • 14.2.9. Others
  • 14.3. Market Size (US$ Mn) Forecast By Drug Type, 2017-2025
    • 14.3.1. Monoclonal Antibodies (mAbs)
    • 14.3.2. Cytokines
    • 14.3.3. Insulin
    • 14.3.4. Peptide hormones
    • 14.3.5. Vaccines
    • 14.3.6. Immunoglobulins
    • 14.3.7. Blood Factors
    • 14.3.8. Peptide antibiotics
    • 14.3.9. Others
  • 14.4. Market Attractiveness Analysis By Drug Type

15. Global Sterile Injectable Drugs Market Analysis 2012-2016 and Forecast 2017-2025, By Application

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Analysis By Application, 2012-2016
    • 15.2.1. Cancer
    • 15.2.2. Diabetes
    • 15.2.3. Cardiovascular Diseases
    • 15.2.4. Musculoskeletal
    • 15.2.5. CNS
    • 15.2.6. Infections
    • 15.2.7. Others
  • 15.3. Market Size (US$ Mn) Forecast By Application, 2017-2025
    • 15.3.1. Cancer
    • 15.3.2. Diabetes
    • 15.3.3. Cardiovascular Diseases
    • 15.3.4. Musculoskeletal
    • 15.3.5. CNS
    • 15.3.6. Infections
    • 15.3.7. Others
  • 15.4. Market Attractiveness Analysis By Application

16. Global Sterile Injectable Drugs Market Analysis 2012-2016 and Forecast 2017-2025, By Route of Administration

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2016
    • 16.2.1. Intravenous
    • 16.2.2. Intramuscular (IM)
    • 16.2.3. Subcutaneous (SC)
    • 16.2.4. Others
  • 16.3. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2025
    • 16.3.1. Intravenous
    • 16.3.2. Intramuscular (IM)
    • 16.3.3. Subcutaneous (SC)
    • 16.3.4. Others
  • 16.4. Market Attractiveness Analysis By Route of Administration

17. Global Sterile Injectable Drugs Market Analysis 2012-2016 and Forecast 2017-2025, By Distribution Channel

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016
    • 17.2.1. Hospital Pharmacies
    • 17.2.2. Retail Pharmacies
    • 17.2.3. Online Pharmacies
  • 17.3. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2025
    • 17.3.1. Hospital Pharmacies
    • 17.3.2. Retail Pharmacies
    • 17.3.3. Online Pharmacies
  • 17.4. Market Attractiveness Analysis By Distribution Channel

18. Global Market Analysis 2012-2016 and Forecast 2017-2025

  • 18.1. Market Size and Y-o-Y Growth
  • 18.2. Absolute $ Opportunity
  • 18.3. Value Chain

19. Research Methodology

List of Table

  • Table 01: North America Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Country
  • Table 02: North America Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Molecule Type
  • Table 03: North America Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Drug Type
  • Table 04: North America Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Application
  • Table 05: North America Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Route of Administration
  • Table 06: North America Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Distribution Channel
  • Table 07: Latin America Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Country
  • Table 08: Latin America Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Molecule Type
  • Table 09: Latin America Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Drug Type
  • Table 10: Latin America Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Application
  • Table 11: Latin America Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Route of Administration
  • Table 12: Latin America Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Distribution Channel
  • Table 13: Europe Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Country
  • Table 14: Europe Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Molecule Type
  • Table 15: Europe Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Drug Type
  • Table 16: Europe Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Application
  • Table 17: Europe Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Route of Administration
  • Table 18: Europe Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Distribution Channel
  • Table 19: Asia Pacific Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Country
  • Table 20: Asia Pacific Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Molecule Type
  • Table 21: Asia Pacific Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Drug Type
  • Table 22: Asia Pacific Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Application
  • Table 23: Asia Pacific Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Route of Administration
  • Table 24: Asia Pacific Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Distribution Channel
  • Table 25: MEA Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Country
  • Table 26: MEA Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Molecule Type
  • Table 27: MEA Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Drug Type
  • Table 28: MEA Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Application
  • Table 29: MEA Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Route of Administration
  • Table 30: MEA Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Distribution Channel
  • Table 31: Global Sterile Injectable Drugs Market Size (US$ Mn) 2012-2016 and Forecast 2017-2025 By Region
  • Table 32: Global Sterile Injectable Drugs Market Size (US$ Mn) 2012-2016 and Forecast 2017-2025 By Molecule Type
  • Table 33: Global Sterile Injectable Drugs Market Size (US$ Mn) 2012-2016 and Forecast 2017-2025 By Drug Type
  • Table 34: Global Sterile Injectable Drugs Market Size (US$ Mn) 2012-2016 and Forecast 2017-2025 By Application
  • Table 35: Global Sterile Injectable Drugs Market Size (US$ Mn) 2012-2016 and Forecast 2017-2025 By Route of Administration
  • Table 36: Global Sterile Injectable Drugs Market Size (US$ Mn) 2012-2016 and Forecast 2017-2025 By Distribution Channel

List of Figure

  • Figure 01: Global Sterile Injectable Drugs Market Value Share, By Molecule Type (2017)
  • Figure 02: Global Sterile Injectable Drugs Market Value Share, By Drug Type (2017)
  • Figure 03: Global Sterile Injectable Drugs Market Value Share, By Application (2017)
  • Figure 04: Global Sterile Injectable Drugs Market Value Share, By Route of Administration (2017)
  • Figure 05: Global Sterile Injectable Drugs Market Value Share, By Distribution Channel (2017)
  • Figure 06: Global Sterile Injectable Drugs Market Value Share, By Region (2017)
  • Figure 07: North America Sterile Injectable Drugs Market Value Share, By Molecule Type (2017)
  • Figure 08: North America Sterile Injectable Drugs Market Value Share, By Drug Type (2017)
  • Figure 09: North America Sterile Injectable Drugs Market Value Share By Application (2017)
  • Figure 10: North America Sterile Injectable Drugs Market Value Share, By Route of Administration (2017)
  • Figure 11: North America Sterile Injectable Drugs Market Value Share, By Distribution Channel (2017)
  • Figure 12: North America Sterile Injectable Drugs Market Value Share, By Country (2017)
  • Figure 13: North America Sterile Injectable Drugs Market Forecast, 2017 and 2025
  • Figure 14: North America Sterile Injectable Drugs Market Size Analysis, 2012-2016
  • Figure 15: North America Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 16: U.S. Sterile Injectable Drugs Market Size Analysis, 2012-2016
  • Figure 17: U.S Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 18: Canada Sterile Injectable Drugs Market Size Analysis, 2012-2016
  • Figure 19: Canada Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 20: North America Sterile Injectable Drugs Market Attractiveness Analysis, By Molecule Type
  • Figure 21: North America Sterile Injectable Drugs Market Attractiveness Analysis, By Drug Type
  • Figure 22: North America Sterile Injectable Drugs Market Attractiveness Analysis, By Application
  • Figure 23: North America Sterile Injectable Drugs Market Attractiveness Analysis, By Route of Administration
  • Figure 24: North America Sterile Injectable Drugs Market Attractiveness Analysis, By Distribution Channel
  • Figure 25: North America Sterile Injectable Drugs Market Attractiveness Analysis, By Country
  • Figure 26: Latin America Sterile Injectable Drugs Market Value Share, By Molecule Type (2017)
  • Figure 27: Latin America Sterile Injectable Drugs Market Value Share, By Drug Type (2017)
  • Figure 28: Latin America Sterile Injectable Drugs Market Value Share By Application (2017)
  • Figure 29: Latin America Sterile Injectable Drugs Market Value Share, By Route of Administration (2017)
  • Figure 30: Latin America Sterile Injectable Drugs Market Value Share, By Distribution Channel (2017)
  • Figure 31: Latin America Sterile Injectable Drugs Market Value Share, By Country (2017)
  • Figure 32: Latin America Sterile Injectable Drugs Market Forecast, 2017 and 2025
  • Figure 33: Latin America Sterile Injectable Drugs Market Size Analysis, 2012-2016
  • Figure 34: Latin America Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 35: Brazil Sterile Injectable Drugs Market Size Analysis, 2012-2016,
  • Figure 36: Brazil Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 37: Mexico Sterile Injectable Drugs Market Size Analysis, 2012-2016
  • Figure 38: Mexico Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 39: Rest of Latin America Sterile Injectable Drugs Market Size Analysis, 2012-2016,
  • Figure 40: Rest of Latin America Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 41: Latin America Sterile Injectable Drugs Market Attractiveness Analysis, By Molecule Type
  • Figure 42: Latin America Sterile Injectable Drugs Market Attractiveness Analysis, By Drug Type
  • Figure 43: Latin America Sterile Injectable Drugs Market Attractiveness Analysis, By Application
  • Figure 44: Latin America Sterile Injectable Drugs Market Attractiveness Analysis, By Route of Administration
  • Figure 45: Latin America Sterile Injectable Drugs Market Attractiveness Analysis, By Distribution Channel
  • Figure 46: Latin America Sterile Injectable Drugs Market Attractiveness Analysis, By Country
  • Figure 47: Europe Sterile Injectable Drugs Market Value Share, By Molecule Type (2017)
  • Figure 48: Europe Sterile Injectable Drugs Market Value Share, By Drug Type (2017)
  • Figure 49: Europe Sterile Injectable Drugs Market Value Share By Application (2017)
  • Figure 50: Europe Sterile Injectable Drugs Market Value Share, By Route of Administration (2017)
  • Figure 51: Europe Sterile Injectable Drugs Market Value Share, By Distribution Channel (2017)
  • Figure 52: Europe Sterile Injectable Drugs Market Value Share, By Country (2017)
  • Figure 53: Europe Sterile Injectable Drugs Market Forecast, 2017 and 2025
  • Figure 54: Europe Sterile Injectable Drugs Market Size Analysis, 2012-2016
  • Figure 55: Europe Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 56: Germany Sterile Injectable Drugs Market Size Analysis, 2012-2016,
  • Figure 57: Germany Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 58: France Sterile Injectable Drugs Market Size Analysis, 2012-2016
  • Figure 59: France Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 60: U.K. Sterile Injectable Drugs Market Size Analysis, 2012-2016,
  • Figure 61: U.K Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 62: Italy Sterile Injectable Drugs Market Size Analysis, 2012-2016
  • Figure 63: Italy Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 64: Spain Sterile Injectable Drugs Market Size Analysis, 2012-2016
  • Figure 65: Spain Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 66: Russia Sterile Injectable Drugs Market Size Analysis, 2012-2016
  • Figure 67: Russia Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 68: Rest of Europe Sterile Injectable Drugs Market Size Analysis, 2012-2016
  • Figure 69: Rest of Europe Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 70: Europe Sterile Injectable Drugs Market Attractiveness Analysis, By Molecule Type
  • Figure 71: Europe Sterile Injectable Drugs Market Attractiveness Analysis, By Drug Type
  • Figure 72: Europe Sterile Injectable Drugs Market Attractiveness Analysis, By Application
  • Figure 73: Europe Sterile Injectable Drugs Market Attractiveness Analysis, By Route of Administration
  • Figure 74: Europe Sterile Injectable Drugs Market Attractiveness Analysis, By Distribution Channel
  • Figure 75: Europe Sterile Injectable Drugs Market Attractiveness Analysis, By Country
  • Figure 76: Asia Pacific Sterile Injectable Drugs Market Value Share, By Molecule Type (2017)
  • Figure 77: Asia Pacific Sterile Injectable Drugs Market Value Share, By Drug Type (2017)
  • Figure 78: Asia Pacific Sterile Injectable Drugs Market Value Share By Application (2017)
  • Figure 79: Asia Pacific Sterile Injectable Drugs Market Value Share, By Route of Administration (2017)
  • Figure 80: Asia Pacific Sterile Injectable Drugs Market Value Share, By Distribution Channel (2017)
  • Figure 81: Asia Pacific Sterile Injectable Drugs Market Value Share, By Country (2017)
  • Figure 82: Asia Pacific Sterile Injectable Drugs Market Forecast, 2017 and 2025
  • Figure 83: Asia Pacific Sterile Injectable Drugs Market Size Analysis, 2012-2016
  • Figure 84: Asia Pacific Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 85: Japan Sterile Injectable Drugs Market Size Analysis, 2012-2016
  • Figure 86: Japan Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 87: China Sterile Injectable Drugs Market Size Analysis, 2012-2016
  • Figure 88: China Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 89: India Sterile Injectable Drugs Market Size Analysis, 2012-2016
  • Figure 90: India Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 91: A&NZ Sterile Injectable Drugs Market Size Analysis, 2012-2016
  • Figure 92: A&NZ Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 93: ASEAN Sterile Injectable Drugs Market Size Analysis, 2012-2016
  • Figure 94: ASEAN Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 95: Rest of APAC Sterile Injectable Drugs Market Size Analysis, 2012-2016
  • Figure 96: Rest of APAC Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 97: Asia Pacific Sterile Injectable Drugs Market Attractiveness Analysis, By Molecule Type
  • Figure 98: Asia Pacific Sterile Injectable Drugs Market Attractiveness Analysis, By Drug Type
  • Figure 99: Asia Pacific Sterile Injectable Drugs Market Attractiveness Analysis, By Application
  • Figure 100: Asia Pacific Sterile Injectable Drugs Market Attractiveness Analysis, By Route of Administration
  • Figure 101: Asia Pacific Sterile Injectable Drugs Market Attractiveness Analysis, By Distribution Channel
  • Figure 102: Asia Pacific Sterile Injectable Drugs Market Attractiveness Analysis, By Country
  • Figure 103: MEA Sterile Injectable Drugs Market Value Share, By Molecule Type (2017)
  • Figure 104: MEA Sterile Injectable Drugs Market Value Share, By Drug Type (2017)
  • Figure 105: MEA Sterile Injectable Drugs Market Value Share By Application (2017)
  • Figure 106: MEA Sterile Injectable Drugs Market Value Share, By Route of Administration (2017)
  • Figure 107: MEA Sterile Injectable Drugs Market Value Share, By Distribution Channel (2017)
  • Figure 108: MEA Sterile Injectable Drugs Market Value Share, By Country (2017)
  • Figure 109: MEA Sterile Injectable Drugs Market Forecast, 2017 and 2025
  • Figure 110: MEA Sterile Injectable Drugs Market Size Analysis, 2012-2016
  • Figure 111: MEA Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 112: GCC Countries Sterile Injectable Drugs Market Size Analysis, 2012-2016
  • Figure 113: GCC Countries Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 114: South Africa Sterile Injectable Drugs Market Size Analysis, 2012-2016
  • Figure 115: South Africa Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 116: North Africa Sterile Injectable Drugs Market Size Analysis, 2012-2016
  • Figure 117: North Africa Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 118: Rest of MEA Sterile Injectable Drugs Market Size Analysis, 2012-2016
  • Figure 119: Rest of MEA Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2025
  • Figure 120: MEA Sterile Injectable Drugs Market Attractiveness Analysis, By Molecule Type
  • Figure 121: MEA Sterile Injectable Drugs Market Attractiveness Analysis, By Drug Type
  • Figure 122: MEA Sterile Injectable Drugs Market Attractiveness Analysis, By Application
  • Figure 123: MEA Sterile Injectable Drugs Market Attractiveness Analysis, By Route of Administration
  • Figure 124: MEA Sterile Injectable Drugs Market Attractiveness Analysis, By Distribution Channel
  • Figure 125: MEA Sterile Injectable Drugs Market Attractiveness Analysis, By Country
  • Figure 126: Global Sterile Injectable Drugs Market Attractiveness Analysis By Region, 2017-2025
  • Figure 127: Global Sterile Injectable Drugs Market Attractiveness Analysis By Molecule Type, 2017-2025
  • Figure 128: Global Sterile Injectable Drugs Market Attractiveness Analysis By Drug Type, 2017-2025
  • Figure 129: Global Sterile Injectable Drugs Market Attractiveness Analysis By Application, 2017-2025
  • Figure 130: Global Sterile Injectable Drugs Market Attractiveness Analysis By Route of Administration, 2017-2025
  • Figure 131: Global Sterile Injectable Drugs Market Attractiveness Analysis By Distribution Channel, 2017-2025
  • Figure 132: Global Sterile Injectable Drugs Market Value Analysis and Forecast, 2016-2025 (US$ Mn)
  • Figure 133: Global Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Mn), 2012-2016
  • Figure 134: Global Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Mn), 2016-2025
Back to Top